Genmab Balance Sheet Health
Financial Health criteria checks 6/6
Genmab has a total shareholder equity of DKK22.7B and total debt of DKK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are DKK24.9B and DKK2.2B respectively. Genmab's EBIT is DKK3.0B making its interest coverage ratio -19.1. It has cash and short-term investments of DKK20.0B.
Key information
0%
Debt to equity ratio
kr.0
Debt
Interest coverage ratio | -19.1x |
Cash | kr.19.99b |
Equity | kr.22.72b |
Total liabilities | kr.2.20b |
Total assets | kr.24.91b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: GE9's short term assets (DKK23.2B) exceed its short term liabilities (DKK1.3B).
Long Term Liabilities: GE9's short term assets (DKK23.2B) exceed its long term liabilities (DKK856.0M).
Debt to Equity History and Analysis
Debt Level: GE9 is debt free.
Reducing Debt: GE9 has not had any debt for past 5 years.
Debt Coverage: GE9 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: GE9 has no debt, therefore coverage of interest payments is not a concern.